Association of cholecystokinin-A receptor gene polymorphism with alcohol dependence in a Japanese population

Alcohol and Alcoholism

Volumn 39, Issue 1, 2004, Pages 25-28

  Miyasaka, Kyoko ^a   Yoshida, Yuki ^a   Matsushita, Sachio ^d   Higuchi, Susumu ^d   Maruyama, Katsuya ^e   Niino, Naoakira ^b   Ando, Fujiko ^b   Shimokata, Hiroshi ^b   Ohta, Shigeo ^d   Funakoshi, Akihiro ^c  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e KURIHAMA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ A RECEPTOR;

ADULT; AGED; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; DELIRIUM TREMENS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FAMILY HISTORY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PSYCHOPATHY; RELATIVE; RISK FACTOR;

ADULT; AGED; ALCOHOL-RELATED DISORDERS; ALDEHYDE DEHYDROGENASE; ALLELES; CHOLECYSTOKININ; GENE FREQUENCY; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR, CHOLECYSTOKININ A;

EID: 9144259962     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agh002     Document Type: Article

References (29)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC.
2. Andreasen, N., Endicott, J. and Spitzer, R. (1977) The family history method using diagnostic criteria; reliability and validity. Archives of General Psychiatry 34, 1229-1235.
3. Beischlag, T. V., Marchese, A., Meador-Woodruff, J. H., Damask, S. P., O'Dowd, B. F., Tyndale, R. F., Van Tol, H. H. M., Seeman, P. and Niznik, H. B. (1995) The human dopamine D5 receptor gene: Cloning and characterization of the 5′-flanking and promoter region. Biochemistry 34, 5960-5970.
4. Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Jagadeeswaran, R., Nogami, H., Briggs, A. H. and Cohn, J. B. (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association 263, 2055-2060.
5. Crawley, J. N. (1991) Cholecystokinin-dopamine interactions. Trends in Pharmacological Sciences 12, 232-236.
6. Funakoshi, A. et al. (2000) Gene structure of human cholecystokinin (CCK) type-A receptor: Body fat content is related to CCK type A receptor gene promoter polymorphism. FEBS Lett. 466, 264-266.
7. Hamilton, M. E. and Freeman, A. S. (1995) Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Research 688, 134-142.
8. Hesselbrock, M., Meyer, R. E. and Keener, J. J. (1986) Psychopathology in hospitalized alcoholics. Archives of General Psychiatry 42, 1050-1055.
9. Higuchi, S., Matsushita, S., Murayama, M., Takagi, S. and Hayashida, M. (1995) Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. American Journal of Psychiatry 152, 1219-1221.
10. Inoue, H., Iannotti, C. A., Welling, C. M., Vaile, R., Donis-Keller, H. and Permutt, M. A. (1997) Human cholecystokinin type A receptor gene: Cytogenetic localization, physical mapping and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics 42, 331-335.
11. Kalivas, P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Research Reviews 18, 75-113.
12. Kamino, K. et al. (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochemical and Biophysical Research Communications 273, 192-196.
13. Ladurelle, N., Durieux, C., Roques, B. P. and Daugé, V. (1994) Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Neuroscience Letters 178, 5-10.
14. Marshall, F. H., Barnes, S., Hughes, J., Woodruff, G. N. and Hunter, J. C. (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Journal of Neurochemistry 56, 917-922.
15. Muramatsu, T., Higuchi, S., Murayama, M., Matsushita, S. and Hayashida, M. (1996) Association between alcoholism and dopamine D4 receptor gene. Journal of Medical Genetics 33, 113-115.
16. Murayama, M., Matsushita, S., Muramatsu, T. and Higuchi, S. (1998) Clinical characteristics and disease course of alcoholics with inactive aldehyde dehydrogenase-2. Alcoholism: Clinical and Experimental Research 22, 524-527.
17. Okubo, T., Harada, S., Higuchi, S. and Matsushita, S. (2000) Genetic polymorphism of the CCK gene in patients with alcohol withdrawal symptoms. Alcoholism: Clinical and Experimental Research 24, 2S-4S.
18. Okubo, T., Harada, S., Higuchi, S. and Matsushita, S. (2002) Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism. Alcoholism: Clinical and Experimental Research 26, 2S-5S.
19. Raimo, E. B., Daeppen, J.-B., Smith, T. L., Danko, G. P. and Schuckit, M. A. (1999) Clinical characteristics of alcoholism in alcohol-dependent subjects with and without a history of alcohol treatment. Alcoholism: Clinical and Experimental Research 23, 1605-1613.
20. Rindi, G., Grant, S. G., Yiangou, Y., Ghatei, M. A., Bloom, S. R., Bautch, V. L., Sorcia, E. and Plak, J. M. (1990) Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormones expression. American Journal of Pathology 136, 1349-1363.
21. SAS Institute Inc. (1998) SAS/STAT™ User's Guide, Release 6.03. SAS Institute, Cary, NC.
22. Self, D. W. and Nestler, E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annual Review of Neuroscience 18, 463-495.
23. Spitzer, R. L., Williams, J. W., Gibbon, M. and First, M. B. (1990) Structured Clinical Interview for DSM-III-R (SCID) User's Guide. American Psychiatric Press, Washington, DC.
24. Shimokata, H. et al. (2000) Distribution of geriatric disease-related genotypes in the National Institute of Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). Journal of Epidemiology 10 (Suppl.), S46-S55.
25. Tachikawa, H., Harada, S., Kawanishi, Y., Okubo, T. and Shiraishi, H. (2000) Novel polymorphisms of human cholecystokinin A receptor gene: An association analysis with schizophrenia. American Journal of Medical Genetics 96, 141-145.
26. Takata, Y., Takeda, S., Kawanami, T., Takiguchi, S., Yoshida, Y., Miyasaka, K. and Funakoshi, A. (2002) Promoter analysis of human cholecystokinin type-A receptor gene. Journal of Gastroenterology 37, 815-820.
27. Wank, S. A. (1995) Cholecystokinin receptors, a review. American Journal of Physiology 269, G628-G646.
28. Woodruff, G. N., Hill, D. R., Boden, P., Pinnock, R., Singh, L. and Hughes, J. (1991) Functional role of brain CCK receptors. Neuropeptides 19, 45-56.
29. Yoshino, A. and Kato, M. (1996) Prediction of 3-year outcome of treated alcoholics by an empirically derived multivariate typology. American Journal of Psychiatry 153, 829-830.